- Report
- January 2022
- 148 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- January 2022
- 278 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- October 2023
- 159 Pages
Global
From €2243EUR$2,350USD£1,879GBP
- Report
- July 2021
- 50 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- November 2023
- 139 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2022
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2022
- 131 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 160 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- March 2022
- 324 Pages
Global
From €9067EUR$9,500USD£7,597GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- September 2022
- 120 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Drug Pipelines
- February 2023
- 127 Pages
Global
From €14311EUR$14,995USD£11,991GBP
- Report
- February 2021
- 35 Pages
Global
€1258EUR$1,318USD£1,054GBP
- Report
- February 2024
- 83 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- November 2021
- 600 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Book
- July 2009
- 1116 Pages

Pregabalin is a drug used to treat a variety of conditions related to the central nervous system, including epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It is a gamma-aminobutyric acid (GABA) analog that works by binding to certain calcium channels in the brain, reducing the release of neurotransmitters that can cause pain and anxiety. Pregabalin is available in both oral and injectable forms, and is often prescribed in combination with other medications.
Pregabalin is a relatively new drug, having been approved by the US Food and Drug Administration in 2004. Since then, it has become a popular treatment option for many conditions related to the central nervous system. It is generally well-tolerated and has fewer side effects than other drugs used to treat similar conditions.
Some of the companies in the Pregabalin market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more